Centene Corporation with ticker code (CNC) now have 19 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between 110 and 71 suggesting an average Analsyt target price of $83.15. Given that the stocks previous close was at $63.70 this is indicating there is a potential upside of 30.5%. Also worth taking note is the 50 day moving average now sits at $66.81 while the 200 day moving average is $71.45. The market capitalization for the company is 34.56B. The stock price for the company is currently 63.83 USD
The potential market cap would be $45,115,865,156 based on the market consensus.
The company has a dividend yield of 1.57%. Other points of data to note are a P/E ratio of 13.03, revenue per share of 247.62 and a 3.68% return on assets.
Centene Corporation is a healthcare company. The Company provides services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. It provides a range of managed healthcare products and services, primarily through Medicaid, Medicare, and commercial products. Its segments include Medicaid, Medicare, Commercial and Other. It offers Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace and the TRICARE program. It also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Medicaid program provides health insurance to low-income families and individuals with disabilities. Medicare is a federal health insurance program for people ages 65 and over, which also covers people under 65 with certain disabilities and people with end-stage renal diseases.
